Home › Research › Getting a diagnosis
Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases
Erkkinen MG, Kim MO, Geschwind MD.. Cold Spring Harbor perspectives in biology, 2018-04-02
Topic: Risk, prevention and care in population studies
Plain-language summary
Neurodegenerative diseases are a common cause of morbidity and cognitive impairment in older adults. Most clinicians who care for the elderly are not trained to diagnose these conditions, perhaps other than typical Alzheimer's disease (AD). Each of these disorders has varied epidemiology, clinical symptomatology, laboratory and neuroimaging features, neuropathology, and management. Thus, it is important that clinicians be able to differentiate and diagnose these conditions accurately. This review summarizes and highlights clinical aspects of several of the most commonly encountered neurodegenerative diseases, including AD, frontotemporal dementia (FTD) and its variants, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), Parkinson's disease (PD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA), and Huntington's disease (HD). For each condition, we provide a brief overview of the epidemiology, defining clinical symptoms and diagnostic criteria, relevant imaging and laboratory features, genetics, pathology, treatments, and differential diagnosis.
What this study adds
Evidence grade: Low
This is a narrative review. This review summarizes clinical aspects of several common neurodegenerative diseases, including Alzheimer's disease, and notes that many clinicians who care for the elderly are not trained to diagnose these conditions. It stresses that accurate differentiation and diagnosis are important, but it reports no treatment, cure, or prevention findings.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Erkkinen, M. G., Kim, M. O., & Geschwind, M. D. (2018). Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harbor perspectives in biology. https://doi.org/10.1101/cshperspect.a033118
Vancouver
Erkkinen MG, Kim MO, Geschwind MD. Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases. Cold Spring Harbor perspectives in biology. 2018. doi:10.1101/cshperspect.a033118. PMID: 28716886.
BibTeX
@article{erkkinen2018-28716886,
author = {Erkkinen, M. G. and Kim, M. O. and Geschwind, M. D.},
title = {{Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases}},
journal = {Cold Spring Harbor perspectives in biology},
year = {2018},
doi = {10.1101/cshperspect.a033118},
pmid = {28716886},
url = {https://doi.org/10.1101/cshperspect.a033118}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- Most clinicians who care for the elderly are not trained to diagnose these conditions, perhaps other than typical Alzheimer's disease (AD).
- Each of these disorders has varied epidemiology, clinical symptomatology, laboratory and neuroimaging features, neuropathology, and management.
- Thus, it is important that clinicians be able to differentiate and diagnose these conditions accurately.
- This review summarizes and highlights clinical aspects of several of the most commonly encountered neurodegenerative diseases, including AD, frontotemporal dementia (FTD) and its variants, progressive supranuclear palsy (PSP), corticobasal degeneration (CBD), Parkinson's disease (PD), dementia with Lewy bodies (DLB), multiple system atrophy (MSA), and Huntington's disease (HD).
- For each condition, we provide a brief overview of the epidemiology, defining clinical symptoms and diagnostic criteria, relevant imaging and laboratory features, genetics, pathology, treatments, and differential diagnosis.
Why it matters
This review summarizes clinical aspects of several common neurodegenerative diseases, including Alzheimer's disease, and notes that many clinicians who care for the elderly are not trained to diagnose these conditions. It stresses that accurate differentiation and diagnosis are important, but it reports no treatment, cure, or prevention findings.
New to this subject? Start with our plain-English guide: Getting a diagnosis →
Study details
- Evidence strengthLow
How this study scored 51/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it. We have no data on impact for its field and year, so that was left out: it earned 48 of the 94 points we could judge it on, which is 51 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Cold Spring Harbor perspectives in biology) |
| Journal's citation record | 3 / 4 | Cold Spring Harbor Perspectives in Biology: journal h-index 301 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 1 / 5 | Rated “low” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2018 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 7 / 7 | Cited 1,128 times (OpenAlex, 2026-10-10) |
| Citations per year | 5 / 5 | 112.8 citations a year over 10 year(s) since 2018 |
| Impact for its field and year | — / 6 | No field-weighted citation impact (OpenAlex has none yet) — left out of this score |
| Cited by studies here | 2 / 6 | Cited by 8 other studies in this library |
| Still being cited | 4 / 4 | Cited 474 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Michael D. Geschwind: h-index 54 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of California, San Francisco: institution h-index 1,915 (OpenAlex) |
| Multicenter collaboration | 0 / 3 | OpenAlex lists 1 institution(s) in 1 country — scores zero (affiliation lists can be incomplete) |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 28716886) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Points | 48 / 94 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 48 of the 94 points we could judge it on is 51 out of 100. |
| Total | 51 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1101/cshperspect.a033118
- PubMed: 28716886
- Original source →
- Free full text: Cold Spring Harbor Perspectives in Biology →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 99.
Later studies that cite this one
8 studies in the alzhub library list this one in their references.
Related studies in Getting a diagnosis from nearby years
Also tagged “lewy”
1,017 studies in the library carry the topic tag “lewy”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,017 tagged studies.